154 related articles for article (PubMed ID: 11179151)
1. FDA refuses companies' request to drop ulcer warning.
Gottlieb S
BMJ; 2001 Feb; 322(7283):385. PubMed ID: 11179151
[No Abstract] [Full Text] [Related]
2. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
Atkinson HG
Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
[No Abstract] [Full Text] [Related]
3. [New study of selective COX-2 inhibitors. Protecting the stomach while risking the heart? (interview by Dr. Beate Schumacher)].
Zeidler H
MMW Fortschr Med; 2001 Sep; 143(35-36):14. PubMed ID: 11584521
[No Abstract] [Full Text] [Related]
4. [COX-2 specific inhibitors: are NSAIDs and the stomach become reconcilied?].
Bannwarth B
Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B79-84. PubMed ID: 11449148
[No Abstract] [Full Text] [Related]
5. Summaries for patients. The cost-effectiveness of cyclooxygenase-2 inhibitors for treating chronic arthritis.
Ann Intern Med; 2003 May; 138(10):I39. PubMed ID: 12755582
[No Abstract] [Full Text] [Related]
6. [Gastric protective pain therapy. What is the advantage of new COX-2 inhibitors?].
Hinz B; Brune K
MMW Fortschr Med; 2000 Mar; 142(11):39-40. PubMed ID: 10786088
[No Abstract] [Full Text] [Related]
7. Cyclooxygenase inhibition: between the devil and the deep blue sea.
Hawkey CJ
Gut; 2002 May; 50 Suppl 3(Suppl 3):III25-30. PubMed ID: 11953329
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular events and COX-2 inhibitors.
Fleming M
JAMA; 2001 Dec; 286(22):2808; author reply 2811-2. PubMed ID: 11735742
[No Abstract] [Full Text] [Related]
9. Arthritis. Should you be taking a COX-2 inhibitor?
Harv Health Lett; 2001 Nov; 27(1):1-3. PubMed ID: 11724695
[No Abstract] [Full Text] [Related]
10. Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs.
Perazella MA; Tray K
Am J Med; 2001 Jul; 111(1):64-7. PubMed ID: 11448662
[No Abstract] [Full Text] [Related]
11. A comparison of the renal and cardiovascular safety of celecoxib and rofecoxib.
Schoors D
Clin Ther; 2002 Mar; 24(3):468-9; author reply 469-70. PubMed ID: 11952030
[No Abstract] [Full Text] [Related]
12. The coxibs, selective inhibitors of cyclooxygenase-2.
Killen JP
N Engl J Med; 2001 Dec; 345(23):1708; author reply 1709. PubMed ID: 11759656
[No Abstract] [Full Text] [Related]
13. COX-2 inhibitors. Magic bullets or merely mortal?
Harv Health Lett; 2000 Feb; 25(4):4. PubMed ID: 10637015
[No Abstract] [Full Text] [Related]
14. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
Jüni P; Rutjes AW; Dieppe PA
BMJ; 2002 Jun; 324(7349):1287-8. PubMed ID: 12039807
[No Abstract] [Full Text] [Related]
15. COX-2 inhibitors and Celebrex: safe or suspect?
Health News; 1999 Jun; 5(7):4. PubMed ID: 10932776
[No Abstract] [Full Text] [Related]
16. Differences between COX-2-specific inhibitors: clinical and economic implications.
Sonnenblick EH
Am J Manag Care; 2002 Oct; 8(15 Suppl):S428-30. PubMed ID: 12416792
[No Abstract] [Full Text] [Related]
17. [Specific inhibitors of cyclooxygenase type 2] ].
Tomasová-Studýnková J
Vnitr Lek; 2002 May; 48(5):403-8. PubMed ID: 12061207
[TBL] [Abstract][Full Text] [Related]
18. COX-2 inhibitors: no pain, no heart gain?
Harv Heart Lett; 2001 Dec; 12(4):2-4. PubMed ID: 11751079
[No Abstract] [Full Text] [Related]
19. [Thinking about the specific cyclooxygenase-2 inhibitors since its recommendation].
Shi G
Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):579-80. PubMed ID: 11758234
[No Abstract] [Full Text] [Related]
20. The coxibs, selective inhibitors of cyclooxygenase-2.
FitzGerald GA; Patrono C
N Engl J Med; 2001 Aug; 345(6):433-42. PubMed ID: 11496855
[No Abstract] [Full Text] [Related]
[Next] [New Search]
